跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 54,815 条关于
“C. diff infection”
全部
54,815
临床试验
44,517
药物
2,288
机构
3,043
资讯
4,967
去年
Recursion Pharmaceuticals Doses First Patient in Phase 2 Study of REC-3964 for Recurrent C. diff Infection
去年
RBX2660 Receives FDA Breakthrough Therapy Designation for Recurrent C. diff Infection
5个月前
Phase 3 C. diff Vaccine Trial Launches at University of Washington to Protect High-Risk Older Adults
去年
Pfizer Advances in C. diff Vaccine Development and Pneumococcal Shot Progress
3个月前
RNA-Based Molecular Test More Accurately Distinguishes Active C. difficile Infection from Colonization
去年
Recursion's AI-Driven C. diff Candidate REC-3964 Enters Phase II Trials
19天前
RedHill Acquires Commercialization Rights to Ferring's Rebyota and Clenpiq in Transformational GI Repositioning
去年
Phase 3b Trial Shows Colonoscopic Administration of Rebyota Effective for Preventing Recurrent C. difficile Infection
去年
Vedanta Biosciences Cuts 20% of Workforce After Microbiome Therapy VE202 Fails Phase 2 Ulcerative Colitis Trial
去年
Fidaxomicin Demonstrates Superior Efficacy in Reducing C. difficile Recurrence Among High-Risk Patients
第 1 页,共 497 页
上一页
下一页